Phosphatidylserine-targeting bis(zinc-dipicolylamine) farnesol inhibits ATP production in cancer cells to overcome multidrug resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phosphatidylserine-targeting bis(zinc-dipicolylamine) farnesol inhibits ATP production in cancer cells to overcome multidrug resistance

Published:2024-12 Issue: Volume:3 Page:100068
ISSN:2667-2405
Container-title:Supramolecular Materials
language:en
Short-container-title:Supramolecular Materials

Author:

Huang Wei,Nie Xuan,Zhou Xiao-Hong,Qiao Lei,Gao Hong-Jie,Zang Jing,Yu Long-Kang,Wang Long-Hai^ORCID,You Ye-Zi

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference44 articles.

1. Novel nanomedicines to overcome cancer multidrug resistance;Su;Drug Resist. Updates,2021

2. Overcoming multidrug resistance (MDR) in cancer by nanotechnology;Bu;Sci. China,2010

3. Drug resistance in breast cancer cells: biophysical characterization of and doxorubicin interactions with membrane lipids;Peetla;Mol. Pharm.,2010

4. The multi-factorial nature of clinical multidrug resistance in cancer;Assaraf;Drug Resist. Updates,2019

5. Multiple molecular mechanisms for multidrug resistance transporters;Higgins;Nature,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP